The distribution of 5-HT6 receptors in rat brain:: an autoradiographic binding study using the radiolabelled 5-HT6 receptor antagonist [125I]SB-258585

被引:125
作者
Roberts, JC
Reavill, C
East, SZ
Harrison, PJ
Patel, S
Routledge, C
Leslie, RA
机构
[1] Addenbrookes Hosp, Addenbrookes Ctr Clin Invest, Cambridge CB2 2GG, England
[2] GlaxoSmithKline, Neurosci Res, Harlow CM19 5AW, Essex, England
[3] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England
关键词
5-HT6; receptor; I-125]SB-258585; striatum; 6-hydroxydopamine; autoradiography; rodent;
D O I
10.1016/S0006-8993(02)02360-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We used the highly selective 5-HT6 receptor radioligand [I-125]SB-258585 (4-iodo-N-[4-methoxy-3-(4-methylpiperazin-1-yl)phenyl] benzene-sulfonamide) to perform autoradiographic binding studies on the rat brain. High levels of specific binding occurred in the corpus striatum, nucleus accumbens, Islands of Calleja and the olfactory tubercle. A high level of binding also appeared in the choroid plexus. Moderate levels occurred in several regions of the hippocampal formation and in certain regions of the cerebral cortex, thalamus, hypothalamus, and substantia nigra; and very low levels in the globus pallidus, cerebellum, other mesencephalic regions, and the rhombencephalon. Displacement of total binding with 10 muM unlabelled SB-214111 (4-bromo-N-[4-methoxy-3-(4-methylpiperazin-1-yl)pheny yl]benzene-sulfonamide), another selective 5-HT6 receptor antagonist, or 10 muM unlabelled methiothepin, reduced binding to barely discernible levels. Some animals received unilateral injections of 6-hydroxydopamine (6-OHDA) into the median forebrain bundle to lesion the nigro-striatal pathway before autoradiographic examination. Effectiveness of the 6-OHDA lesions in the substantia nigra and striatum was confirmed with tyrosine hydroxylase immunohistochemistry. Such lesions resulted in no significant changes in [I-125]SB-SB258585 binding in any brain region examined, suggesting that 5-HT6 receptors in the striatum are not located on dendritic, somatic or terminal elements of dopaminergic neurones. Thus, the striatal binding sites seen in this study may be on intrinsic GABAergic or cholinergic neurones, or on terminals of projection neurones from the thalamus or cerebral cortex. The 5-HT6 receptor ligand binding seen here in the striatum, accumbens, olfactory tubercle, Islands of Calleja, cerebral cortex and hippocampus are in concordance with previous immunohistochemical studies, and suggest a possible involvement of 5-HT6 receptors in locomotor control, cognition, memory, and control of affect. The high levels of binding observed in the choroid plexus in this study have not been reported before. This finding suggests that 5-HT6 receptors could play a role in the control of cerebrospinal fluid dynamics. (C) 2002 Elsevier Science BY. All rights reserved.
引用
收藏
页码:49 / 57
页数:9
相关论文
共 16 条
[1]   Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats [J].
Bentley, JC ;
Bourson, A ;
Boess, FG ;
Fone, KCF ;
Marsden, CA ;
Petit, N ;
Sleight, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (07) :1537-1542
[2]   Involvement of 5-HT6 receptors in nigro-striatal function in rodents [J].
Bourson, A ;
Boess, FG ;
Bös, M ;
Sleight, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (07) :1562-1566
[3]  
BOURSON A, 1995, J PHARMACOL EXP THER, V274, P173
[4]   5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046):: A potent, selective, and orally bioavailable 5-HT6 receptor antagonist [J].
Bromidge, SM ;
Brown, AM ;
Clarke, SE ;
Dodgson, K ;
Gager, T ;
Grassam, HL ;
Jeffrey, PM ;
Joiner, GF ;
King, FD ;
Middlemiss, DN ;
Moss, SF ;
Newman, H ;
Riley, G ;
Routledge, C ;
Wyman, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) :202-205
[5]  
Gerard C, 1996, SYNAPSE, V23, P164, DOI 10.1002/(SICI)1098-2396(199607)23:3<164::AID-SYN5>3.3.CO
[6]  
2-C
[7]   Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system [J].
Gerard, C ;
Martres, MP ;
Lefevre, K ;
Miquel, MC ;
Verge, D ;
Lanfumey, L ;
Doucet, E ;
Hamon, M ;
ElMestikawy, S .
BRAIN RESEARCH, 1997, 746 (1-2) :207-219
[8]   Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors [J].
Hamon, M ;
Doucet, E ;
Lefevre, K ;
Miquel, MC ;
Lanfumey, L ;
Insausti, R ;
Frechilla, D ;
Del Rio, J ;
Vergé, D .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (02) :S68-S76
[9]   Characterization of [125I]-SB-258585 binding to human recombinant and native 5-HT6 receptors in rat, pig and human brain tissue [J].
Hirst, WD ;
Minton, JAL ;
Bromidge, SM ;
Moss, SF ;
Latter, AJ ;
Riley, G ;
Routledge, C ;
Middlemiss, DN ;
Price, GW .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (07) :1597-1605
[10]  
MONSMA FJ, 1993, MOL PHARMACOL, V43, P320